Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori

Aim: This was a prospective, multicenter, single-arm intervention, against historical controls, study of the efficacy of a vonoprazan-based 7-day triple regimen with metronidazole (VPZ-AMPC-MNZ) as a first-line therapy for eradicating clarithromycin-resistant Helicobacter pylori (H. pylori). Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Sue, Soichiro, Suzuki, Yuichi, Sasaki, Tomohiko, Kaneko, Hiroaki, Irie, Kuniyasu, Komatsu, Kazuto, Maeda, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488100/
https://www.ncbi.nlm.nih.gov/pubmed/37685510
http://dx.doi.org/10.3390/jcm12175443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488100/
https://www.ncbi.nlm.nih.gov/pubmed/37685510
http://dx.doi.org/10.3390/jcm12175443

Ejemplares similares